An Exploratory Study to Evaluate the Ability of the Citrus Polyphenol Hesperidin to Improve Insulin Sensitivity in Healthy Subjects and to Ameliorate Insulin Resistance in Obese Subjects
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Hesperidin (Primary)
- Indications Insulin resistance
- Focus Biomarker; Therapeutic Use
- Acronyms EHIS
- 07 Nov 2019 Biomarkers information updated
- 30 Jan 2013 New trial record